Medartis Holding AG

As of June 30, 2026, Medartis Holding AG carries a market capitalization of 1.11B, placing it among publicly traded companies globally. Its enterprise value stands at 1.30B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medartis Holding AG's next confirmed earnings release is scheduled for March 2, 2027.

As of June 30, 2026, Medartis Holding AG has 12.45M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Medartis Holding AG maintains a current ratio of 3.36, meaning it holds 3.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

As of the close on October 22, 2026, Medartis Holding AG's stock has gained approximately 14.07% over the past 52 weeks. The 50-day moving average sits at 92.28, while the 200-day moving average is 91.05.

As of June 30, 2026, Medartis Holding AG holds 27.96M in cash and equivalents against 224.57M in total debt, resulting in a net debt position of -27.96M. Total book value stands at 305.41M, with working capital of 159.32M providing operational flexibility.